The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study

• Published in: Annals of hematology Vol. 99; no. 2; pp. 359 - 361
• Main Authors: Mori, Hirotaka, Sukegawa, Masumi, Fukatsu, Masahiko, Sano, Takahiro, Takahashi, Hiroshi, Harada, Kayo, Kimura, Satoshi, Ohkawara, Hiroshi, Nakamura, Kenichi, Mita, Masayuki, Saito, Tomiyoshi, Hamazaki, Yoichi, Ohta, Masatsugu, Ikezoe, Takayuki
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2020; Springer Nature B.V
• Subjects: Aniline Compounds - therapeutic use; Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Contraindications, Drug; Cross-Sectional Studies; Drug Substitution; Endothelium, Vascular - drug effects; Endothelium, Vascular - metabolism; Endothelium, Vascular - pathology; Hematology; Humans; Interleukin-1beta - blood; Letter to the Editor; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy; Male; Medicine; Medicine & Public Health; Middle Aged; Myocardial Infarction - chemically induced; Myocardial Infarction - etiology; Myocytes, Cardiac - drug effects; Myocytes, Cardiac - metabolism; Myocytes, Cardiac - pathology; Nitriles - therapeutic use; Oncology; Protein Kinase Inhibitors - adverse effects; Protein Kinase Inhibitors - pharmacology; Protein Kinase Inhibitors - therapeutic use; Pyrimidines - adverse effects; Pyrimidines - pharmacology; Pyrimidines - therapeutic use; Quinolines - therapeutic use; Risk Factors
• ISSN: 0939-5555; 1432-0584
• DOI: 10.1007/s00277-019-03896-4